Sharecare Awarded Three-year NCQA Accreditation for Case Management
Accreditation for its complex case management capabilities complements Sharecare's existing three-year NCQA accreditations for Population Health Program and Wellness and Health PromotionATLANTA, April
GlobeNewswireApr 24 09:00 ET
Sharecare to Report First Quarter Fiscal 2024 Financial Results on Thursday, May 9
ATLANTA, April 24, 2024 (GLOBE NEWSWIRE) -- Sharecare (Nasdaq: SHCR), the digital health company that helps people manage all their health in one place, today announced that it will report first qua
GlobeNewswireApr 24 07:00 ET
Sharecare, Inc. (SHCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors To...
Stockhouse Apr 21 11:00 ET
Sharecare Is Maintained at Equal-Weight by Morgan Stanley
Sharecare Is Maintained at Equal-Weight by Morgan Stanley
Dow JonesApr 15 13:01 ET
Express News | Morgan Stanley Maintains Equal-Weight on Sharecare, Lowers Price Target to $1
Moomoo 24/7Apr 15 12:51 ET
Sharecare Teams up With Anthem Blue Cross and Blue Shield on Jump Shot for Health Initiative to Support Georgia Title 1 Schools
State Health Benefit Plan members to engage in four-month steps challenge to reward two Georgia public schools with refurbished basketball courts Initiative made possible by community partners Sharecare, Anthem Blue
GlobeNewswireApr 11 08:30 ET
Cannell Capital LLC Sends Letter to Sharecare, Inc. Director Alan G. Mnuchin
Alta, Wyoming--(Newsfile Corp. - April 4, 2024) - J. Carlo Cannell, the Managing Member of Cannell Capital LLC, sent the following letter to Sharecare, Inc. Director Mr. Alan G. Mnuchin on Thursday Ap
newsfileApr 4 11:30 ET
Express News | Sharecare Shares Are Trading Lower After BTIG Downgraded the Stock From Buy to Neutral
Moomoo 24/7Apr 1 14:06 ET
12 Health Care Stocks Moving In Monday's Intraday Session
GainersSunshine Biopharma (NASDAQ:SBFM) stock rose 86.3% to $0.11 during Monday's regular session. The company's market cap stands at $11.2 million. Xilio Therapeutics (NASDAQ:XLO) stock rose 25.93% t
BenzingaApr 1 12:31 ET
Sharecare Cut to Neutral From Buy by BTIG
Sharecare Cut to Neutral From Buy by BTIG
Dow JonesApr 1 12:23 ET
Sharecare Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/01/2024 — BTIG Downgrades Buy → Neutral 06/02/2023 789.36% BTIG → $5 Reiterates → Buy 03/30/2023 255.7
BenzingaApr 1 12:12 ET
BTIG Research Downgrades Sharecare to Neutral From Buy
BTIG Research Downgrades Sharecare to Neutral From Buy.
MT NewswiresApr 1 08:03 ET
Buy Rating Affirmed for Sharecare Amidst Strong Performance and Strategic Growth Initiatives
TipRanksApr 1 07:16 ET
Sharecare, Inc. on Alert: Navigating the Perils of Shareholder Activism and Takeover Threats
TipRanksMar 31 02:01 ET
Earnings Call Summary | Sharecare(SHCR.US) Q4 2023 Earnings Conference
The following is a summary of the Sharecare, Inc. (SHCR) Q4 2023 Earnings Call Transcript:Financial Performance:Sharecare reported revenues of $105 million for Q4 and $445 million for 2023, achieving
moomoo AIMar 28 21:22 ET · Conference Call
Recap: Sharecare Q4 Earnings
Sharecare (NASDAQ:SHCR) reported its Q4 earnings results on Thursday, March 28, 2024 at 04:05 PM.Here's what investors need to know about the announcement.EarningsSharecare beat estimated earnings by
BenzingaMar 28 17:55 ET
Sharecare Inc (SHCR) Reports Earnings: A Mixed Bag Against Analyst Expectations
Yahoo FinanceMar 28 17:32 ET
Express News | Sharecare Says Given The Strategic Review Process Is Ongoing, Among Other Factors, The Company Will Not Provide Financial Guidance For The Quarter Ending March 31, 2024, Or Fiscal Year 2024, At This Time
Moomoo 24/7Mar 28 16:10 ET
Earnings Flash (SHCR) SHARECARE Posts Q4 Revenue $105.3M, Vs. Street Est of $115M
04:10 PM EDT, 03/28/2024 (MT Newswires) -- Earnings Flash (SHCR) SHARECARE Posts Q4 Revenue $105.3M, vs. Street Est of $115M
MT NewswiresMar 28 16:10 ET
Sharecare Q4 Adj EPS $(0.03) Beats $(0.06) Estimate, Sales $105.28M Miss $114.99M Estimate
Sharecare (NASDAQ:SHCR) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.06) by 50 percent. This is a 50 percent decrease over losses of $(0.02) per shar
BenzingaMar 28 16:08 ET
No Data
No Data